Company ProfilePremium

Bajaj Consumer Care Limited

Company Profile Analysis

Tickers: BAJAJCON.NS, 533229.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Bajaj Consumer Care Limited - Company showcase

Year Founded & Workforce

2006

522 Employees

Bajaj Consumer Care Limited logo

Bajaj Consumer Care Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Bajaj Consumer Care Limited Overview

Bajaj Consumer Care is a mid-sized, debt-free Indian FMCG company whose economics are anchored in a single dominant franchise: Bajaj Almond Drops Hair Oil (ADHO), which commands an estimated 63%+ share of India's light hair oil (LHO) segment and is distributed through roughly 4.3 million retail outlets. Around ADHO the company has built adjacencies in coconut oil (Bajaj 100% Pure), ethnic/ayurvedic oils (Brahmi Amla, Amla Aloe Vera, Sarson Amla, Kailash Parbat), skin care (Nomarks), premium niche oils (Natyv Soul, 100% Pure range) and, since 2025, South Indian naturals via the Banjara's acquisition. After a decade of stagnant revenue (FY2021–FY2025) and a promoter-pledge overhang in 2019, BCCL entered a sharp operating upturn in FY2026—revenue crossed INR 1,000 Cr for the first time and gross margin expanded roughly 650 bps—driven by ADHO volume recovery, low-unit-pack expansion and the Project Aarohan route-to-market overhaul. Capital allocation favours tender-offer buybacks over dividends.


Company's own description

In its exchange filings, BCCL describes its single reportable segment as "Cosmetics, Toiletries and Other Personal Care Products" (NSE integrated filings, Q4 FY2025 and Q2 FY2026). The Business Responsibility & Sustainability Report (BRSR) for FY2026 describes the business as FMCG manufacturing, marketing and distribution of fast-moving consumer products, primarily hair care and other personal care products, and states that the company operates in hair care, hair styling and skin care categories. The FY2026 Annual Report (the company's 20th, themed "Shaping the Next Era of Growth") frames the strategy as strengthening the core personal care categories while extending that core into new consumer segments and need-states.

Independent characterisation

BCCL is best understood as a brand-owner and distribution company in the value-added hair oil (VAHO) category, with manufacturing as a supporting rather than defining capability. Its competitive moat rests on (i) the near-monopoly brand position of ADHO in light hair oils—a perfumed, non-sticky, almond-and-Vitamin-E positioned oil aimed historically at urban and semi-urban women; (ii) a general-trade distribution network covering several million outlets; and (iii) cost discipline that historically produced EBITDA margins near 20% on modest scale.

The structural weakness is concentration: hair and coconut oils accounted for approximately 98% of FY2026 standalone turnover (per BRSR-based reporting summarised by ScanX), and ADHO alone has historically represented the large majority of revenue (90%+ at the time of the 2010 IPO per CRISIL; the current ADHO share of revenue is not publicly disclosed). Diversification attempts (Nomarks from 2013, Natyv Soul, Almond Drops skin & hair, 100% Pure Coconut, Banjara's in 2025) have broadened the catalogue but have not yet materially diluted ADHO dependence.

Business and revenue model

DimensionCharacterisation
Revenue model~100% product sales (FMCG goods); no service, subscription or licensing revenue of significance disclosed
Value chain positionBrand owner; procures raw materials (light liquid paraffin, refined/vegetable oils, copra, almond oil, fragrances, packaging); manufactures at two owned plants plus contract manufacturing units; sells via distributors to retailers
Customer types (direct)Distributors/super-stockists (general trade), modern trade chains, e-commerce marketplaces and quick-commerce platforms, CSD (canteen stores), export distributors
End consumersIndian households across urban and rural markets; core consumer historically women aged 15–45 in Hindi-speaking markets (HSM); Banjara's extends into South India
Channel mixGeneral trade dominant; organised trade (modern trade + e-commerce) growing. In Q1 FY2027 both general trade and organised trade grew in the "strong 20s" per the company's investor communication
Price architectureMass-premium within hair oils; increasing reliance on low-unit packs (LUPs) and sachets which grew faster than the brand average in Q1 and Q2 FY2027
Geographic mix~97% domestic India; exports ~3% of standalone turnover to 35+ countries (BRSR FY2026), principally Nepal, Bangladesh, Middle East/GCC and Africa

End-markets served

  1. Light hair oil (LHO) — core; ADHO is category leader.

  2. Coconut hair oil — the largest hair oil sub-category in India (≈47% of category value in 2025 per Ken Research), where BCCL is a challenger via Bajaj 100% Pure Coconut Oil and Bajaj Gold 100% Pure Coconut Oil.

  3. Amla / ethnic / ayurvedic hair oils — Bajaj Brahmi Amla, Amla Aloe Vera, Sarson Amla, Amla Shikakai.

  4. Cooling hair oils — Bajaj Kailash Parbat, Bajaj Cool Almond Drops.

  5. Skin care — Nomarks (anti-marks creams/face care), Almond Drops body lotion and soap, Banjara's natural skin care (aloe vera gels, facial kits, herbal powders).

  6. Hair care beyond oils — Almond Drops shampoo/conditioner/serum; Banjara's hair care powders and shampoos.

  7. Premium natural oils — Natyv Soul and Bajaj 100% Pure (castor, olive, jojoba, kalonji, virgin coconut), largely digital/e-commerce led.

  8. Oral care (legacy) — Bajaj Black Tooth Powder (historical; current scale not disclosed).

Strategy

Stated strategic themes (FY2026 Annual Report and recent earnings calls, paraphrased)

  1. Strengthen and grow the core (ADHO) — sustain double-digit volume growth through price-point packs, sachets, distribution depth and consumer-metric improvement (penetration, brand health).

  2. Extend the core into adjacent need-states — Almond Drops hair & skin care, coconut oils, ethnic oils, serums and styling.

  3. Scale the non-ADHO portfolio, especially Banjara's (South India + HSM rollout) and Bajaj 100% Pure Coconut Oil.

  4. Premiumisation — premium ADHO variants, Natyv Soul, 100% Pure specialty oils.

  5. Route-to-market transformation (Project Aarohan) — expand direct reach roughly 10% per year for four to five years.

  6. Revive international — new leadership and distributor model in Nepal, Bangladesh and MEA.

  7. Calibrated innovation — management signalled "calibrated and spaced-out" innovations in specific opportunity areas rather than a scattershot launch pipeline (Q3 FY2026 call per ScanX).

  8. Capital return — recurring tender buybacks rather than dividends.

Initiative register (last 24 months)

InitiativeLaunch / dateScopeTargets / status
Project Aarohan 1.0Pilot Q1 FY2025 (UP, MP); scaled H2 FY2025–FY2026RTM redesign with a leading strategy consultant: move from sub-distributors to direct distributors in key towns, geo-tagging of all direct outlets (85%+ of urban outlets tagged), improved servicing of high-potential outletsExpected ~1.4x improvement in urban outlet reach; achieved 100,000+ new outlets, 1,100+ distribution partners; ~670 vans closed; distribution expansion contributed ~2–3 pp to Q2 FY2027 volume growth
Project Aarohan 2.0Q2 FY2027Extend direct distribution ~10% in urban and >10% in rural markets across all 27 statesMedium-term target to lift direct distribution from ~50–60% of larger peers' level to ~75–80%
Banjara's integrationFeb 2025 onwardsAcquire, demerge operating undertaking into BCCL (effective 1 May 2026), extend into HSM, modern trade and exportsIntegration declared complete in Q1 FY2027
Price-point pack strategyFY2026–FY2027Sachets and LUPs for ADHOLUPs outperforming; key growth engine
Pricing actionsQ3 FY2027 (planned)~5% consumer price action (2–3% list price, rest via grammage)To mitigate raw-material inflation
International resetMar 2026New Head of International (ROW, MEA & Nepal), distributor changesQ1 FY2027 recovery
Digital media / e-commerceOngoingDigital-first brands, connected TV ("TV dark market"), e-commerce ratings strategye.g., 9.7 mn reach / 20 mn views campaign (Q2 FY2025)
ESG: ZLD & ETPFY2026Zero Liquid Discharge at Paonta Sahib; ETP upgrade at GuwahatiCompleted per BRSR FY2026
CSR: Miyawaki tree plantationFY2025Urban forestry projectReported in Q2 FY2025 presentation
Capital returnJul 2024; Jul–Sep 2025Two tender buybacks at INR 290INR 166.5 Cr and INR 186.6 Cr executed

Management guidance

BCCL does not issue formal numerical revenue or margin guidance. Qualitative guidance from recent calls: (i) targeting consistent double-digit growth over the long term (Q1 FY2027); (ii) A&P to be maintained around mid-teens % of revenue (14.6% in Q1 FY2027); (iii) inflationary pressure expected into Q2 and Q3 FY2027, with pricing to offset; (iv) ~10% annual expansion of direct coverage for four to five years (Q3 FY2026 call).

Products & Services

All products fall within the single segment. Pricing models are standard FMCG MRP-based retail pricing; specific price points are generally not disclosed in filings. Launch years are given where disclosed.

Almond Drops franchise (core)

ProductDescription / key attributesTarget customerLaunch / latestNotes
Bajaj Almond Drops Hair Oil (ADHO)Premium perfumed light, non-sticky hair oil positioned on almond oil and Vitamin EWomen 15–45, urban and rural, HSM coreLegacy (pre-2006 heritage); continuous pack renovationsFlagship; ~63%+ LHO share (SBI Securities); LUPs/sachets growing faster than brand average in FY2027
ADHO low-unit packs & sachetsAffordable price-point packs; partial grammage reductions used as pricing leverRural and price-sensitive consumersOngoing; key growth engine in Q1–Q2 FY2027Underlying volume growth in early teens adjusted for pack-size reductions (Q1 FY2027)
Bajaj Cool Almond Drops Hair OilCooling variant of ADHOSummer/cooling-oil usersDisclosed in ARCompetes with Emami Navratna
Bajaj Almond Drops Almond Argan Hair OilADHO with argan oilPremium-seeking urban womenDisclosed in ARPremiumisation variant
Bajaj Almond Drops Serum with OilHair serum with almond oilUrban, styling-orientedSerum sachet launched Apr 2024 in West Bengal and Odisha GTHair styling entry
Bajaj Almond Drops Shampoo & ConditionerHair cleansing/conditioning regimeExisting ADHO usersAnti-Hairfall Shampoo launched c. FY2022Regime extension
Bajaj Almond Drops Moisturising Soap / Soap with Almond OilBathing soapMass consumersc. FY2021–FY2022Competes with HUL, Wipro, Godrej
Bajaj Almond Drops Nourishing Body LotionLightweight almond-based body lotionUrban womenAug 2023Skin care extension
Bajaj Almond Drops Ultralight Body Lotion (Summer)Aloe vera, almond oil, Vitamin ESummer usageApr 2024Seasonal variant

The Almond Drops Hair & Skin Care range (non-ADHO) grew ~33% in Q2 FY2025 per that quarter's earnings call and has strong e-commerce traction.

Coconut oil range

ProductDescriptionTargetLaunchNotes
Bajaj 100% Pure Coconut OilPure coconut oil, hair and edible-grade positioningMass households, HSM and Maharashtrac. FY2021–FY2022Consistent share gains in several HSM states and Maharashtra (Q1 FY2025 presentation); 14% distribution increase in Q3 FY2025
Bajaj Gold 100% Pure Coconut OilPremium/variant coconut oilValue-premiumQ2 FY2025Disclosed in Q2 FY2025 presentation
Bajaj Coco Onion Non-Sticky Hair OilCoconut + onion, non-stickyHair-fall concerned consumersc. FY2022Rides onion-oil trend
Bajaj Coco Jasmine Hair OilCoconut with jasmine fragranceMassDisclosed in AREthnic/perfumed coconut
Bajaj 100% Pure Virgin Coconut OilCold-pressed virgin coconutPremium, e-commerceDisclosed in ARPart of 100% Pure range

Ethnic / ayurvedic range

ProductDescriptionNotes
Bajaj Brahmi Amla Ayurvedic Hair OilTraditional heavy hair oil with brahmi and amlaLegacy brand
Bajaj Amla Aloe Vera Hair OilAmla with aloe veraLaunch disclosed in AR
Bajaj Sarson Amla Hair OilMustard + amla"New" in recent AR
Bajaj Amla ShikakaiLow-price amla variantPrice-conscious consumers
Bajaj Jasmine Hair OilJasmine-perfumed hair oilLegacy
Bajaj Kailash Parbat Cooling OilAyurvedic cooling oil with sandal and almond extractsLaunched c. FY2013–FY2014
Bajaj Zero Grey Hair OilAnti-greying positioningDisclosed in AR
Bajaj GulabjalRose waterSales hit by planned market hygiene corrections in Q1 FY2025
Bajaj 100% Pure HennaNatural hair colour/conditioningc. FY2022

Bajaj 100% Pure specialty oils

Castor Oil, Olive Oil, Jojoba Oil, Kalonji Oil, Virgin Coconut Oil — single-ingredient natural oils targeted at e-commerce and modern trade consumers seeking "clean" ingredients (FY2022 Annual Report).

Nomarks (skin care)

ProductDescriptionNotes
Bajaj Nomarks creamsAyurvedic anti-marks face creamsAcquired Aug 2013; 6.9% market share in its segment in 2015-16 (company history); relaunch in FY2019 with strongest share in Uttar Pradesh
Bajaj Nomarks Ayurveda rangeFace washes and treatmentsCurrent portfolio
Bajaj Nomarks Hand SanitizerSanitizerLaunched 2020 (pandemic)

Natyv Soul (premium, digital-first)

Natyv Soul Pure Argan Oil from Morocco; Natyv Soul Oil from Californian Almonds; Natyv Soul Hair Serum; Natyv Soul Hair Masque; hair oils with Marula Oil, Buriti Oil, Sacha Inchi Oil, Rosehip Oil and Apple Seed Oil (FY2022 Annual Report). Positioned as premium personal care for urban digital consumers; scale not disclosed.

Banjara's (acquired 2025)

Product familyDescriptionDistribution
Facial kitsHerbal/natural facial kitsCosmetic stores, pharmacies, supermarkets, grocery
Herbal powdersMultani mitti, herbal face/hair powders70,000+ outlets across five South Indian states at acquisition
Aloe vera gelsSkin and hair gelsSame
Shampoos and hair care powdersNatural hair careSame
Hair oilsNatural hair oilsSame

Founded 1991 in Hyderabad; revenue above INR 50 Cr with ~14% four-year CAGR at acquisition (Storyboard18). Strategy: deepen South India, introduce in HSM, scale in modern trade and exports. A dedicated Associate Vice President (Banjaras), Mallikeswaran, was appointed SMP from 3 March 2026.

Oral care (legacy)

Bajaj Black Tooth Powder — traditional tooth powder historically manufactured at Udaipur; current scale not disclosed.

Financial Narrative

Income statement (consolidated)

Sources: Net sales, operating profit, PBT, net income — Anand Rathi/CMOTS consolidated; FY2026 PBT and net income restated per Q2 FY2027 filing (INR 23,175.30 lakh and INR 19,056.48 lakh); as originally reported FY2026 PAT was INR 190.18 Cr. Gross profit, EBIT, EBITDA, EPS, A&P — S&P Global via StockAnalysis. DPS — Equitymaster/CMOTS.

Margin profile

Margins are computed on S&P standardised revenue; minor rounding differences versus company presentations exist. Note the low effective tax rate, reflecting area-based tax benefits at the Himachal Pradesh/Assam manufacturing locations and tax-efficient treasury income.

Revenue CAGR (analyst-computed): FY2022–FY2026 four-year CAGR 7.3%; FY2021 (net sales INR 921.81 Cr) to FY2026 five-year CAGR 4.8%. Net income five-year CAGR FY2021 (INR 223.13 Cr) to FY2026 is -3.1%; FY2021 remains the peak profit year owing to pandemic-era demand and very benign input costs.

Commentary. The five-year record divides into two eras. FY2021–FY2025 was a period of stagnation: net sales oscillated between INR 880 Cr and INR 984 Cr, while gross margin compressed from ~58% to ~54% as light liquid paraffin (a crude derivative) and vegetable oil prices spiked after 2021. Management responded by holding A&P at 15–18% of sales to defend ADHO share, which squeezed EBITDA margin to a trough of 12.7% in FY2025. FY2025 was additionally depressed by deliberate general-trade inventory "market hygiene" corrections in the first half (disclosed in Q1 and Q2 FY2025 earnings calls) as Project Aarohan restructured the distributor base.

FY2026 was the inflection. Net sales grew ~21% to INR 1,164.7 Cr; quarterly growth accelerated from low single digits organically in Q1 FY2026 to 32.7% in Q3 FY2026 and ~31% in Q4 FY2026. Gross margin expanded roughly 650 bps to ~60%, aided by softer paraffin and oil costs in the first nine months and by mix/pricing. EBITDA margin recovered to ~19% for the year and exited at 23.4% in Q4 FY2026. The Banjara's consolidation contributed roughly INR 60–80 Cr of incremental revenue (analyst estimate from subsidiary-level disclosures), meaning organic growth was still in the mid-teens.

Quarterly trajectory (consolidated)

Sources: Company results via Outlook Business, FPJ, Upstox, JM Financial, Arihant/CMOTS, Kotak Neo. Q4 FY2026 revenue is derived (FY2026 restated revenue INR 1,171.41 Cr minus Q1–Q3); Q4 FY2026 EBITDA derived from reported 23.4% margin; Q4 FY2026 PBT derived (FY2026 PBT minus Q1–Q3); Q1 FY2026 and Q4 FY2026 EPS analyst-computed. YoY growth for Q1–Q2 FY2026 computed against FY2025 quarters (Q1FY25 ~246, Q2FY25 ~234); Q2 FY2026 PAT growth versus INR 40.3 Cr (approx.). Note the Q1 FY2026 PAT appears as INR 37.93 Cr (as originally reported) and INR 38.28 Cr (restated).

H1 FY2027 (consolidated): revenue INR 674.40 Cr (+25%); net sales INR 674.1 Cr (+27.8%); EBITDA INR 167.6 Cr (+85%); PBT INR 174.0 Cr (+78.3%); PAT INR 140.9 Cr (+74.8%); operating cash flow INR 112.85 Cr (company results, 14 Oct 2026).

Q2 FY2027 cost detail: COGS INR 133.5 Cr (+26.8% YoY); employee costs INR 34.3 Cr (+0.3%); A&P INR 41.7 Cr (+7.2%); other expenses INR 40.0 Cr (+4.8%); D&A INR 3.8 Cr; finance cost INR 0.3 Cr. The near-flat A&P and employee lines against 25% revenue growth explain most of the margin expansion—operating leverage rather than gross margin, which actually declined sequentially (Q1 FY2027 gross margin 61.8% vs 63.0% in Q4 FY2026) as raw-material indices rose (light liquid paraffin index 152 vs 98 in Q4 FY2026; refined mustard oil 155 vs 138; copra 171 vs 149) (JM Financial summary of company disclosure).

Balance sheet (consolidated, year-end)

Source: S&P Global via StockAnalysis (converted from INR million). Debt consists entirely of lease liabilities; BCCL has no bank borrowings. Standalone net worth per BRSR FY2026 was INR 793.36 Cr; the gap to consolidated equity reflects acquisition accounting and subsidiary losses/eliminations.

Commentary. BCCL's balance sheet is conservatively, even excessively, liquid: treasury assets of INR 400–630 Cr represented 43–68% of total assets over the period. The decline in treasury from INR 629 Cr (FY2024) to INR 406 Cr (FY2026) is fully explained by three uses of cash—the July 2024 buyback (INR 166.5 Cr plus buyback tax), the September 2025 buyback (INR 186.6 Cr), and the Banjara's acquisition (cash acquisition outflow INR 62.4 Cr in FY2026 for the second tranche, with the first tranche paid in FY2025). The FY2026 jump in intangibles to INR 103.2 Cr reflects Banjara's brand recognition on consolidation. Receivables rose from 8 days of sales (FY2022) to 24–27 days (FY2025–FY2026), consistent with the shift toward modern trade, e-commerce and direct distributors under Aarohan.

Cash flow (consolidated)

Source: S&P Global via StockAnalysis. Company-reported FY2026 operating cash flow was INR 198.86 Cr (JM Financial); FY2026 buyback spend reported as INR 190.2 Cr (Indiantelevision). FY2025 OCF was depressed by a ~INR 28 Cr receivables build and Aarohan transition.

Commentary. The business is highly cash generative (FCF conversion of net income ~70–90% in normal years) and capital-light (capex under 1% of sales until FY2026). FY2026 capex rose to INR 32.8 Cr—the highest in the period—likely reflecting capacity/automation and environmental upgrades (ZLD at Paonta Sahib, ETP upgrade at Guwahati per BRSR), though the precise breakdown is not disclosed. BCCL has distributed more than 100% of FCF to shareholders in each of the last five years, drawing down the treasury corpus; this policy is not sustainable indefinitely at the FY2025 cash generation level, but is comfortably covered at the FY2026–FY2027 run-rate.

Ratios

Sources: ROE, ROA, ROIC, ROCE, current/quick ratios, D/E, net debt/EBITDA, asset and inventory turnover — S&P Global via StockAnalysis. Interest coverage and cash conversion cycle components are analyst-computed on year-end balances (interest is lease interest only, so coverage is not economically meaningful).

Commentary. ROIC (excluding the cash pile) is exceptional at 38–78%, illustrating a brand franchise that needs almost no operating capital. ROE is suppressed by surplus cash; the buybacks have been the lever to lift ROE from ~16% (FY2025) to ~25% (FY2026). The lengthening cash conversion cycle (19 to 42 days) is the most notable operating-quality watchpoint and reflects receivables growth and higher inventory ahead of price increases.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Income Statement and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Net sales (INR Cr)

879.96960.87984.12964.831,164.71

Revenue growth YoY (%)

-4.59.22.4-2.020.7

Gross profit (INR Cr)

509.3519.2540.0522.3705.0

Operating income — EBIT (INR Cr)

169.4133.1145.5117.7205.6

EBITDA excl. other income (INR Cr)

173.6138.1150.3122.6220.9

Operating profit incl. other income (INR Cr)

212.55178.28199.97162.98248.05

Pre-tax income (INR Cr)

206.47168.79189.04152.29231.75

Net income (INR Cr)

169.63139.22155.43125.26190.56

EPS basic (INR)

11.509.4810.899.0314.21

EPS diluted (INR)

11.499.4710.899.0314.21

Dividend per share (INR)

8.05.03.000

Advertising & promotion (INR Cr)

147.7174.5162.2141.3173.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Gross margin (%)

57.954.054.954.160.5

EBITDA margin (%)

19.714.415.312.719.0

Operating (EBIT) margin (%)

19.313.914.812.217.7

Pre-tax margin (%)

23.517.619.215.819.9

Net margin (%)

19.314.515.813.016.4

A&P as % of net sales (%)

16.818.216.514.614.9

Effective tax rate (%)

17.817.517.818.017.8

Income Statement and Margin Analysis (%) (Quarterly)

MetricQ1FY26Q2FY26Q3FY26Q4FY26Q1FY27Q2FY27

Revenue from operations (INR Cr)

273.39265.27306.09326.6341.57332.83

Revenue growth YoY (%)

11.113.432.730.724.925.5

EBITDA (INR Cr)

41.948.756.976.484.483.3

EBITDA margin (%)

15.818.618.623.424.725.0

PBT (INR Cr)

46.1351.4356.4377.887.2786.76

Net profit (INR Cr)

38.2842.2946.3763.6370.7570.15

PAT growth YoY (%)

2.25.083.2105.384.865.9

EPS (INR)

2.793.243.444.875.425.37

Balance Sheet and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (INR Cr)

931.5924.4983.6901.1945.1

Cash & equivalents (INR Cr)

11.514.022.730.939.2

Cash + short-term investments + trading securities (INR Cr)

623.4591.1629.1452.1406.1

Long-term investments (INR Cr)

005.065.610.0

Short-term debt incl. current lease liabilities (INR Cr)

03.24.82.54.3

Long-term debt incl. lease liabilities (INR Cr)

06.14.01.711.5

Total debt (INR Cr)

09.38.84.215.8

Net debt (INR Cr; negative = net cash)

-623.4-581.8-620.3-448.0-390.3

Shareholders' equity (INR Cr)

809.6789.7830.6747.9755.0

Goodwill (INR Cr)

43.043.043.043.043.0

Other intangibles (INR Cr)

1.20.60.70.6103.2

Goodwill & intangibles (INR Cr)

44.243.643.743.6146.2

Inventory (INR Cr)

57.151.356.254.866.1

Receivables (INR Cr)

19.430.844.371.975.6

Accounts payable (INR Cr)

45.545.040.249.942.4

Working capital (INR Cr)

628.8606.5647.8507.2433.5

Book value per share (INR)

54.8855.3658.1754.5756.39

Cash Flow and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (INR Cr)

128.5101.5116.365.1196.9

Capital expenditure (INR Cr)

10.76.44.35.432.8

Free cash flow (INR Cr)

117.895.0112.159.7164.1

FCF margin (%)

13.49.911.46.214.1

Cash acquisitions (INR Cr)

000062.4

Dividends paid (INR Cr)

118.059.0114.100

Share buybacks (INR Cr)

0100.20.6206.2190.2

Total shareholder distributions (INR Cr)

118.0159.2114.7206.2190.2

Distributions as % of FCF (%)

100168102345116

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE (%)

21.717.419.215.925.3

ROA (%)

11.69.09.57.814.0

ROIC (%)

77.955.757.237.850.9

ROCE (%)

20.816.617.315.626.7

Current ratio (x)

6.325.865.494.483.49

Quick ratio (x)

5.444.984.673.602.77

Debt / equity (x)

00.010.010.010.02

Net debt / EBITDA (x)

-3.59-4.21-4.13-3.65-1.81

Interest coverage EBIT / interest (x)

194137143219128

Asset turnover (x)

0.961.031.031.021.26

Inventory turnover (x)

7.398.158.267.987.64

Days sales outstanding (days)

8.011.716.427.223.7

Days inventory outstanding (days)

56.242.446.245.252.5

Days payables outstanding (days)

44.837.233.041.233.7

Cash conversion cycle (days)

19.416.929.631.242.5

Geography Overview

GeographyFY2026

India — share of standalone turnover (%)

97

International — share of standalone turnover (%)

3

Region / Country Details

Region / countryRecent trendReasonSource

Bangladesh

+103% YoY in Q2 FY2025; weakness in FY2026; double-digit growth in Q1 FY2027

Transition from national distributor to own distribution (completed Q1 FY2025); political disruption in 2024–2025; recovery on low base

Q1/Q2 FY2025 calls; Q1 FY2027 results

Nepal

Challenged in FY2026; double-digit growth in Q1 FY2027

Distribution partner changes and new leadership

FY2026 commentary; Q1 FY2027 results

UAE / MEA

Expansion to 100+ stores in UAE (Q1 FY2025); "West Asia crisis" disruptions cited in Q1 FY2027

Geopolitical disruption

Q1 FY2025 call; Q1 FY2027 presentation

International overall

Mid-single-digit decline YoY in Q3 FY2026; "strong comeback" in Q1 FY2027 after leadership and distribution partnership changes

New Head of International Business (ROW, MEA & Nepal) from 1 Mar 2026

Q3 FY2026 call; Kotak Neo

Share Price & Returns

Reference pointPriceReturn to INR 479.10 (15 Oct 2026)

Oct 2021 month-end (unadjusted)

231.30

~107% (5-year, price only)

Oct 2023 month-end (unadjusted)

232.30

~106% (3-year)

Oct 2025 month-end

276.65

~73% (1-year)

52-week high

691.15-31%

52-week low

220.05+118%

Share Price and Market Valuation

MetricFY2022FY2023FY2024FY2025FY2026

Year-end share price (INR, adjusted)

153.43146.39212.10157.25347.00

Market capitalisation (INR Cr)

2,4092,1673,0252,2454,533

Enterprise value (INR Cr)

1,8181,5482,4531,8204,263

P/E (x)

14.215.619.517.923.8

EV/EBITDA (x)

10.511.216.314.919.8

EV/Sales (x)

2.071.612.491.893.66

P/B (x)

2.982.743.643.006.00

Dividend per share (INR)

8.05.03.000

Buyback yield (%)

00.42.92.83.6

Valuation Snapshot

MultipleValueBasis

Market cap

~INR 6,258 Cr

130.62 mn shares

Enterprise value

~INR 5,868 Cr

Less FY2026 net cash INR 390 Cr

P/E (TTM)

~25.1x

TTM EPS ~INR 19.10 (Q3 FY2026–Q2 FY2027)

EV/EBITDA (TTM)

~19.5x

TTM EBITDA ~INR 301 Cr

EV/Sales (TTM)

~4.5x

TTM revenue ~INR 1,307 Cr

P/B

~8.3x

FY2026 consolidated equity INR 755 Cr

Analyst Ratings & Targets

BrokerDateRatingTarget (INR)

Choice Institutional Equities

15 Oct 2026

BUY (DCF-based)

715

SBI Securities

—

"Pick of the Week"

—

Consensus

—

Not reliably available

An aggregator-cited "consensus INR 279" from five analysts is clearly stale (pre-rerating) and disregarded

Dividend History

FYDPS (INR)TypePayout ratio (%)

FY2020

2.0

Final

16

FY2021

10.0

Final/interim

66

FY2022

8.0

Interim INR 4 + Final INR 4

70

FY2023

5.0

Final

51

FY2024

3.0

Interim (Feb 2024)

28

FY2025

0—0

FY2026

0—0

Share Price & Returns — 2020

YearRouteSize (INR Cr)Price (INR)Shares
2020

Open market

———

2022 (FY2023)

—

~100

——
2024

Tender

166.49290

~5.74 mn

2025

Tender

186.60290

6.43 mn

Analyst Conclusions

Management guidance

No numerical guidance. Management targets consistent double-digit growth over the long term, expects input-cost inflation through Q2–Q3 FY2027, plans ~5% consumer price action in Q3 FY2027, and intends ~10% annual expansion in direct reach (Aarohan 2.0). A&P is expected to stay near mid-teens % of revenue.

Consensus growth expectations

Not reliably available. Choice Institutional Equities' BUY/INR 715 call implies expectations of sustained mid-teens-plus earnings growth; S&P's forward P/E of ~23x at INR 483 implies forward EPS near INR 21 (analyst inference from S&P forward P/E).

Bull case (three arguments)

  1. The volume engine is real, not just pricing. ADHO delivered >30% domestic revenue growth in Q1 and Q2 FY2027 with double-digit unit volumes, while distribution contributed only 2–3 pp — meaning brand pull and LUP penetration are doing the heavy lifting. If Aarohan 2.0 lifts direct reach toward 75–80% of peer levels, there is multi-year volume runway.

  2. Operating leverage on a fixed cost base. Employee and other expenses grew 0–5% in Q2 FY2027 against 25% revenue growth; EBITDA margin reached 25.0%. Even with gross margin pressure, each incremental INR 100 Cr of revenue at ~60% gross margin drops disproportionately to EBITDA.

  3. Capital allocation optionality. With ~INR 390 Cr net cash, ~INR 160–200 Cr annual FCF and no debt, BCCL can continue buybacks (~3–4% annual yield) and still fund bolt-on acquisitions like Banjara's, compounding EPS faster than net income.

Bear case (three arguments)

  1. Margin peak risk. Light liquid paraffin index rose from 98 to 152 within two quarters; gross margin already slipped from 63.0% (Q4 FY2026) to 61.8% (Q1 FY2027). FY2021–FY2025 showed how quickly input inflation can compress EBITDA margin from ~20% to ~13%.

  2. Base effects and growth normalisation. FY2026's 21% growth and H1 FY2027's 25% growth lap a weak FY2025 base (which included distributor inventory corrections); from H2 FY2027 the comparison base is far tougher (Q3–Q4 FY2026 grew 31–33%).

  3. Concentration and execution risk. ~98% of revenue from oils, heavy management turnover (MD, finance, strategy, marketing, CS, internal audit within ~13 months), and a history of adjacencies not scaling suggest the portfolio diversification thesis remains unproven.

Key catalysts and monitorables (next 12 months)

MonitorableWhy it mattersTiming
Q3 FY2027 results (likely Jan 2027)First quarter against a 32.7% growth base; impact of ~5% price/grammage action on volumeJan 2027
Gross margin trajectory vs LLP/copra/mustard indicesDetermines whether 24–25% EBITDA margin holdsQuarterly
Aarohan 2.0 metrics (outlets, distributors, rural reach)Validates volume runwayQuarterly calls
Banjara's HSM rollout and revenue disclosureTests diversification thesisFY2027–FY2028
International (Nepal, Bangladesh, MEA)Recovery sustainability under new leadershipQuarterly
Capital return announcementThird buyback or dividend reinstatementTypically July board meetings
Management stabilityFilling CMO and internal audit roles; board refreshOngoing
Competitive activity in LHO/serumsShare defenceOngoing

Analyst verdict

Bajaj Consumer Care has executed one of the sharpest operating turnarounds in Indian mid-cap FMCG over the past eighteen months. After four years in which revenue went nowhere and EBITDA margins halved, FY2026 delivered ~21% revenue growth, ~650 bps of gross margin expansion and a 52% jump in profit; H1 FY2027 accelerated further, with EBITDA up 85% and margins at a record ~25%. Crucially, the growth is volume-led — ADHO unit volumes are growing at double digits — and is supported by a credible, measurable distribution programme (Aarohan) rather than one-off pricing.

The franchise economics are outstanding: a near-monopoly in light hair oils, ROIC above 50%, minimal capex needs, and a debt-free balance sheet that funds both bolt-on M&A and recurring buybacks. At ~25x TTM earnings and ~19–20x TTM EV/EBITDA after the 15 October sell-off, the stock trades at a discount to large-cap HPC peers despite superior near-term growth.

The risks, however, are concentrated and well-known. BCCL is still effectively a one-brand, one-category company whose margins are hostage to crude-linked paraffin and vegetable-oil prices — and those indices have turned sharply upward. The second half of FY2027 laps a demanding 31–33% growth base, and management continuity has been poor, with nearly every senior function changing hands since mid-2025. The diversification story (Banjara's, coconut, skin care) is promising but unproven at scale.

On balance, the evidence supports a constructive but margin-sensitive view: the structural improvements in distribution and volume are durable, but investors should underwrite normalised EBITDA margins closer to 20–22% rather than the 25% peak, and look to Q3 FY2027 volume data after the planned price/grammage action as the decisive test. Execution on Aarohan 2.0 and stable leadership are the factors most likely to determine whether the 2026 re-rating proves sustainable.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleSinceBackground / notes

Kushagra Nayan Bajaj

Non-Executive Chairman

Long-standing (Chairman since at least 2014)

Promoter; also Chairman & MD of Bajaj Hindusthan Sugar Ltd; DIN 00017575

Naveen Pandey

Managing Director

1 Jul 2025 (5-year term to 30 Jun 2030)

20+ years leadership experience across P&L, strategy, innovation, sales, marketing, investor and regulatory affairs; 5+ years in general management including ~2 years as MD of a listed company (per board outcome filing, 24 Jun 2025); DIN 09584377

Aakash Gupta

Head-Finance (Senior Management Personnel)

1 Jul 2025

Replaced Richard D'Souza (resigned)

Jignesh Nagda

Company Secretary

Appointed 13 Jul 2026

Succeeds Vivek Mishra (previously Head-Legal & Company Secretary)

Mallikeswaran

Associate Vice President (Banjaras), SMP

3 Mar 2026

Leads acquired business

—

Head — International Business (ROW, MEA & Nepal), SMP

1 Mar 2026

Appointed after Deepak Himan's exit

Deepak Himan

Former Head-Strategy & International Business

Resigned 1 Jan 2026; relieved 28 Feb 2026

Departure

Sanath R Pulikkal

Former Chief Marketing Officer

Joined Jun 2024; exited Apr 2026

Per exchange4media, 17 Apr 2026

Harshit Shah

Former Head-Internal Audit

Resignation announced 2026

Per ScanX

—

Senior management personnel with prior experience at Bharti Tele-Ventures and UB Group

Resigned; cessation 31 Mar 2026

NSE filing, 22 Dec 2025

Board of Directors

DirectorCategoryNotes

Kushagra Nayan Bajaj

Non-Executive Chairman, Promoter

Retires by rotation periodically

Naveen Pandey

Managing Director (Executive)

From 1 Jul 2025

Sumit Malhotra

Non-Executive, Non-Independent

Former MD

Apoorv Bajaj

Non-Executive, Non-Independent (promoter relative)

—

Jagdish Acharya

Independent

Chaired 2024 AGM in Chairman's absence

Anupam Dutta

Independent

Present at 2024 AGM

Lilian Jessie Paul

Independent

Appointed 2019

Jitendra Ananda Mahajan

Independent (Additional Director)

Appointed 14 Oct 2026 for five years, subject to shareholder approval

—

Independent

Resigned effective 14 Oct 2026 citing personal medical reasons and professional commitments

Two further independent directors

Independent

—

Shareholding Trend

Holder categoryJun 2025Sep 2025Dec 2025Mar 2026Jun 2026

Promoters (%)

40.9540.9542.9742.9742.96

Foreign institutions (%)

10.9510.129.7016.5916.1

Mutual funds (%)

16.3214.6115.0213.41

not disaggregated

Other domestic institutions (%)

0.500.660.720.860.8

Retail and others (%)

31.2733.6631.5926.1726.0

Competitive Landscape

Competitors by Segment

CategoryCompetitorKey brandsPositioning vs BCCL

Light hair oil

Marico

Hair & Care, Shanti Badam Amla (historical LHO challenger), Hair & Care Oil in Serum (Aug 2024)

Largest VAHO player overall; main LHO challenger

Light/almond oils

Dabur India

Dabur Almond Hair Oil, Vatika

Strong in amla; almond variants compete directly

Coconut oil

Marico

Parachute (~57% coconut oil share, dated)

Dominant; BCCL is a small challenger

Amla / ayurvedic oils

Dabur India

Dabur Amla

Category leader in amla

Cooling oils

Emami

Navratna (leader in cooling oil, ~55% share historically)

Competes with Kailash Parbat, Cool Almond Drops

Therapeutic hair oils

Emami

Kesh King

Adjacent

Mass hair care / ayurvedic

Hindustan Unilever

Indulekha, Clinic Plus, Dove (Dove Elixir hair oil historically)

Scale and distribution advantage

Ayurvedic / naturals

Patanjali Ayurved

Kesh Kanti, Patanjali coconut/amla

Price aggressor

Naturals skin & hair (vs Banjara's)

Himalaya Wellness

Himalaya face packs, aloe gels

Pharmacy-led naturals

Naturals skin care

Biotique, Lotus Herbals, VLCC, Patanjali

Herbal skin care

Banjara's competitive set

Skin care (vs Nomarks)

HUL, Emami, Himalaya

Glow & Lovely, Fair & Handsome, Himalaya

Nomarks is niche

Soaps/lotions

HUL, Wipro Consumer, Godrej Consumer, ITC

Lux, Santoor, Cinthol, Vaseline (HUL)

Almond Drops soap/lotion are small entrants

Regional hair oils

Various (e.g., Cavinkare, Jyothy Labs)

Meera, regional oils

South India competition for Banjara's

Peer Comparison FY2026

CompanyMarket cap (INR Cr)P/E (x)Annual PAT (INR Cr)EV/EBITDA (x)

Hindustan Unilever

428,09628.615,04069.6

Godrej Consumer Products

86,79045.41,86121.5

Dabur India

66,70133.81,89513.8

Colgate-Palmolive India

48,14235.71,32555.0

Emami

15,92121.377521.2

Jyothy Labs

6,89124.33339.4

Bajaj Consumer Care

6,43428.919018.4

Peer Comparison FY2026 (Annual)

MetricBajaj Consumer Care FY2026Marico FY2025Dabur FY2025Emami FY2025

Revenue (INR Cr)

1,16510,83112,5633,809

Company Snapshot

$134.5M

Revenue

522

Employees

2006

Founded

Udaipur, India

Headquarters

SWOT Analysis

Strengths

  • Dominant category leadership: ADHO holds 63%+ of LHO (SBI Securities), versus ~50% at IPO (CRISIL 2010) — share has risen over 15 years.
  • Debt-free, cash-rich balance sheet: net cash INR 390 Cr at FY2026 with total debt only INR 15.8 Cr of lease liabilities (S&P).
  • Exceptional capital efficiency: ROIC of 50.9% in FY2026 and 77.9% in FY2022 (S&P).
  • Demonstrated operating leverage: Q2 FY2027 EBITDA rose 71% on 25.5% revenue growth as employee costs grew just 0.3% and A&P 7.2% (company results).
  • Volume-led growth: ADHO domestic grew >30% in Q1 and Q2 FY2027 with double-digit unit volume growth (investor presentations).
  • Shareholder returns discipline: two consecutive INR 290 tender buybacks (INR 166.5 Cr in 2024; INR 186.6 Cr in 2025) at premiums to market; promoters abstained (company filings).
  • No promoter pledge since March 2020 (BSE disclosure), removing the 2019 overhang.

Weaknesses

  • Portfolio concentration: hair and coconut oils ~98% of FY2026 standalone turnover (BRSR via ScanX).
  • Revenue stagnation history: net sales were lower in FY2025 (INR 964.8 Cr) than FY2021 (INR 921.8 Cr) adjusted for inflation, and FY2021 PAT (INR 223 Cr) remains above FY2026 (INR 190.6 Cr).
  • Diversification under-delivery: Nomarks (acquired 2013) and Natyv Soul have not been disclosed as material contributors a decade on.
  • Senior management churn: MD, Head-Finance, Head-Strategy & International, CMO, CS, Head-Internal Audit and another SMP all changed between Jun 2025 and Jul 2026 (exchange filings).
  • Working-capital drift: cash conversion cycle lengthened from 19 days (FY2022) to 42.5 days (FY2026) (analyst-computed).
  • Small international footprint: ~3% of turnover with recurring volatility (BRSR FY2026; Q3 FY2026 call).

Opportunities

  • Distribution headroom: direct distribution at ~50–60% of larger peers' level with a 75–80% target (Choice Institutional Equities, Oct 2026).
  • South India via Banjara's: acquisition adds 70,000+ outlets across five southern states, a region where BCCL was under-represented (Q3 FY2025 presentation).
  • Coconut oil challenger play: coconut is ~47% of category value (Ken Research); Bajaj 100% Pure has posted consistent share gains in HSM and Maharashtra.
  • Premiumisation: Almond Drops hair & skin care range grew ~33% (Q2 FY2025 call); serums and argan variants extend price ladder.
  • M&A firepower: INR 390 Cr net cash supports further bolt-on acquisitions.
  • Category growth: hair oil market projected at ~5–6% CAGR through 2030–2032 (Ken, Mordor, Grand View).

Threats

  • Raw-material inflation: LLP index 152 vs 98 in Q4 FY2026; refined mustard oil 155 vs 138; copra 171 vs 149 (Q2 FY2027 disclosure).
  • Competitive innovation: Marico's oil-in-serum format (Aug 2024) targets the same almond/Vitamin E positioning.
  • Consumer shift among younger urban women toward serums, leave-ins and non-oil hair care.
  • Geopolitics: West Asia crisis cited as disrupting the international business (Q1 FY2027).
  • Pricing elasticity risk: planned ~5% consumer price action in Q3 FY2027 (2–3% price plus grammage) could dent volumes.
  • Valuation compression risk: stock fell ~35% from ~INR 690 to ~INR 447 between June and September 2026 despite record earnings.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
5 May 2025FY2025 results: Q4 FY2025 consolidated PAT INR 30.98 Cr (-12.9% YoY), net sales INR 246.73 Cr (+5.3%); secretarial auditor appointed for FY2026–FY2030Trough year closes
16 May 2025Completes acquisition of remaining 51% of Vishal Personal CareBanjara's becomes wholly owned
24 Jun 2025Naveen Pandey named MD from 1 Jul 2025; Aakash Gupta Head-Finance; Richard D'Souza resignsCEO transition
30 Jun 2025Jaideep Nandi's five-year MD term endsLeadership change
–Q1 FY2026 results: PAT ~INR 38 Cr (+2% YoY); ex-Vishal revenue growth 3.7%Weak start to FY2026
24 Jul 2025Board approves INR 186.6 Cr buyback at INR 290 and VPCL demerger scheme; stock falls ~4%Capital return; structure simplification
29 Aug 2025Shareholders approve buyback via postal ballot—
1 Sep 2025Record date fixed (5 Sep; later cited 9 Sep in Letter of Offer)Discrepancy in sources on record date
11–17 Sep 2025Buyback tender window; 16,979 valid bids for 30.08 mn shares (~4.7x)Strong shareholder participation
25 Sep 2025Buyback completion; share capital to 130.62 mn shares; promoter stake to 42.97%Float reduction
10 Nov 2025Q2 FY2026 results: PAT INR 42.29 Cr; revenue INR 265.3 CrGrowth accelerating
22 Dec 2025Senior management resignation (cessation 31 Mar 2026)Management churn
1 Jan 2026Deepak Himan (Head-Strategy & International) resignsManagement churn
21 Jan 2026Q3 FY2026: revenue +32.7%, PAT +83%, gross margin ~60%; stock down ~4.6% on day, +16% next sessionEarnings inflection confirmed
22 Jan 2026Management guides ~10% annual direct coverage expansion for 4–5 yearsDistribution roadmap
Jan 2026 (approx.)GST demand order of INR 27.21 lakh from Ambala tax authorities; company says no material impactMinor tax matter
28 Feb 2026New Head of International (ROW, MEA & Nepal) from 1 Mar; AVP Banjaras from 3 MarOrg rebuild
9 Apr 2026NCLT approves VPCL schemeRestructuring cleared
17 Apr 2026FY2026 results: revenue first time above INR 1,000 Cr; consolidated PAT ~INR 190 Cr (+52%); Q4 PAT INR 63.6 Cr (doubled); EBITDA margin 23.4%Record year
17 Apr 2026CMO Sanath R Pulikkal exitsMarketing leadership change
1 May 2026VPCL scheme becomes effectiveFinancials re-presented
Jun 2026Stock reaches 52-week high near INR 691Re-rating peak
11 Jul 202620th Annual Report and BRSR FY2026 filedDisclosure
13 Jul 2026Q1 FY2027: revenue +25%, PAT +85% to INR 70.75 Cr, EBITDA +101%, margin 24.7%; Jignesh Nagda appointed CS; stock -1.8% to -2%Strong quarter; market sceptical on margins
15 Jul 2026Q1 FY2027 earnings call transcript filed—
Jul–Sep 2026Stock falls ~35% from ~INR 690 to ~INR 447 low in early SeptemberValuation reset / input cost fears
–Head-Internal Audit Harshit Shah resignsControl-function turnover
Q2 FY2027Project Aarohan 2.0 launched across 27 statesDistribution expansion
14 Oct 2026Q2 FY2027: revenue INR 332.8 Cr (+25.5%), PAT INR 70.15 Cr (+66%), EBITDA margin 25.0%; independent director Narayanan resigns; Jitendra Ananda Mahajan appointedSustained momentum
15 Oct 2026Stock falls 7.7% to INR 479.10 despite results; Choice Institutional Equities retains BUY, TP INR 715Market focus on raw-material inflation

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

1 chart
Revenue by Region (%): India — share of standalone turnover was 97% in FY2026.
Bajaj Consumer Care Limited — Revenue by Region (%)
Series (%)FY2026
India — share of standalone turnover97
International — share of standalone turnover3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. NSE: Outcome of Board Meeting, 24 Jun 2025 (nsearchives.nseindia.com)
  2. NSE: Outcome, 5 May 2025 (nsearchives.nseindia.com)
  3. NSE: Buyback record date intimation, 1 Sep 2025 (nsearchives.nseindia.com)
  4. NSE: Change in Management, 22 Dec 2025 (nsearchives.nseindia.com)
  5. NSE: Change in Senior Management, 28 Feb 2026 (nsearchives.nseindia.com)
  6. NSE: Annual Report FY2026 (20th) (nsearchives.nseindia.com)
  7. NSE: BRSR FY2026 (nsearchives.nseindia.com)
  8. NSE: Integrated filing Q4 FY2025 (nsearchives.nseindia.com)
  9. NSE: Integrated filing Q2 FY2026 (nsearchives.nseindia.com)
  10. NSE: AGM outcome 2024 (nsearchives.nseindia.com)
  11. Company investor presentations (Q1 FY2025, Q2 FY2025, Q3 FY2025) and call transcripts (9 Aug 2024, 12 Nov 2024) (bajajconsumercare.com)
  12. BSE: Q3 FY2026 results with auditor review (bsmedia.business-standard.com)
  13. BSE: Promoter non-encumbrance declaration, Apr 2020 (bseindia.com)
  14. CRISIL IPO grading, Jun 2010 (crisil.com)
  15. StockAnalysis (S&P Global) income statement, balance sheet, cash flow, ratios (stockanalysis.com)
  16. Anand Rathi financial results (anandrathi.com)
  17. Fyers P&L and peer comparison (fyers.in)
  18. Upstox shareholding (upstox.com)
  19. IIFL shareholding (indiainfoline.com)
  20. MarketsMojo shareholding (marketsmojo.motilaloswal.com)
  21. Arihant/CMOTS monthly prices and dividends (arihantcapital.com)
  22. Digrin price history (digrin.com)
  23. Equitymaster dividend history (equitymaster.com)
  24. Outlook Business, Q1 FY2027 (outlookbusiness.com)
  25. Free Press Journal, Q1 and Q2 FY2027 (freepressjournal.in)
  26. Upstox News, Q2 FY2027 (upstox.com)
  27. JM Financial, 15 Oct 2026 (jmfinancialservices.in)
  28. Kotak Neo, Q2 FY2027 (kotakneo.com)
  29. Indiantelevision, Q2 FY2027 and FY2026 (indiantelevision.com)
  30. DSIJ / Choice Institutional Equities (insights.dsij.in)
  31. SBI Securities Pick of the Week — of the Week_Bajaj Consumer Care Ltd..pdf (sbisecurities.in)
  32. Arihant/CMOTS, Q3 FY2026 (arihantcapital.com)
  33. Business Standard, 2025 buyback (business-standard.com)
  34. Angel One, buyback history (angelone.in)
  35. FilingReader, buyback completion (filingreader.com)
  36. exchange4media, Vishal Personal Care deal (exchange4media.com)
  37. Storyboard18, deal rationale (storyboard18.com)
  38. PTI/The Week, MD appointment (theweek.in)
  39. Business Standard, Oct 2019 promoter sale (business-standard.com)
  40. ScanX, BRSR summary and SMP changes (scanx.trade)
  41. Ken Research, India hair oil market (kenresearch.com)
  42. Revelio Labs headcount estimates (reveliolabs.com)

Primary (company / exchange filings)

Financial data aggregators

News and research

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.